ST Pharm Co.Ltd (237690) — Long-term Investment Intensity

Latest as of December 2019: 0.9%

ST Pharm Co.Ltd (237690) has a Long-term Investment Intensity of 0.9% as of December 2019. Long-term investments of ₩3.01 Billion represent 0.9% of total assets of ₩341.08 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ST Pharm Co.Ltd (237690) shareholders funds for net asset value and shareholders' equity analysis.

LT Investment Intensity

0.9%
LT Investments / Total Assets

Long-term Investments

₩3.01 Billion
KRW

Total Assets

₩341.08 Billion
KRW

Country

Korea
KQ

ST Pharm Co.Ltd Long-term Investment Intensity (2016–2019)

This chart shows how ST Pharm Co.Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 0.9%, reflecting long-term investments of ₩3.01 Billion against total assets of ₩341.08 Billion KRW. Also explore balance sheet size of ST Pharm Co.Ltd for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for ST Pharm Co.Ltd (2016–2019)

The table below presents the year-by-year Long-term Investment Intensity for ST Pharm Co.Ltd from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 237690 company net worth.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 0.9% ₩3.01 Billion ₩341.08 Billion ▲ +0.6 pp
2018 0.3% ₩1.06 Billion ₩345.51 Billion ▲ +0.2 pp
2017 0.1% ₩471.42 Million ₩381.50 Billion ▼ -0.2 pp
2016 0.3% ₩1.04 Billion ₩367.78 Billion
pp = percentage points